皮肤狼疮和皮肤狼疮红斑疾病面积和严重程度指数工具。
Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.
机构信息
Philadelphia VA Medical Center, Philadelphia, PA, USA.
出版信息
Rheum Dis Clin North Am. 2010 Feb;36(1):33-51, vii. doi: 10.1016/j.rdc.2009.12.001.
Abstract
This article provides an overview of cutaneous lupus erythematosus, including classification schemes, disease subtypes, and therapy. It also describes the Cutaneous Lupus Erythematosus Disease Area and Severity Index, a novel clinical outcome instrument that quantifies cutaneous activity and damage in cutaneous lupus erythematosus.
摘要
本文概述了红斑狼疮，包括分类方案、疾病亚型和治疗方法。它还描述了红斑狼疮疾病面积和严重程度指数，这是一种新型的临床结果评估工具，可量化红斑狼疮的皮肤活动和损伤。
相似文献
1
Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.皮肤狼疮和皮肤狼疮红斑疾病面积和严重程度指数工具。
Rheum Dis Clin North Am. 2010 Feb;36(1):33-51, vii. doi: 10.1016/j.rdc.2009.12.001.
2
Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus.大疱性系统性红斑狼疮患者的坏疽性脓皮病。
Eur J Dermatol. 2002 Sep-Oct;12(5):485-7.
3
Clinical image: bullous lupus erythematosus.临床影像：大疱性红斑狼疮。
Rheumatology (Oxford). 2018 Sep 1;57(9):1601. doi: 10.1093/rheumatology/key084.
4
Widespread vesiculobullous eruption in a 16-year-old male.一名16岁男性出现广泛的水疱大疱性皮疹。
Acta Dermatovenerol Alp Pannonica Adriat. 2010 Oct;19(3):19-22.
5
The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus.CLASI（皮肤红斑狼疮疾病面积和严重程度指数）：一种用于皮肤红斑狼疮的疗效评估工具。
J Invest Dermatol. 2005 Nov;125(5):889-94. doi: 10.1111/j.0022-202X.2005.23889.x.
6
Bullous systemic lupus erythematosus: response to dapsone in two patients.大疱性系统性红斑狼疮：两名患者对氨苯砜的反应
Indian J Dermatol Venereol Leprol. 2005 Jan-Feb;71(1):54-6. doi: 10.4103/0378-6323.13795.
7
Vesiculobullous rash in a patient with systemic lupus erythematosus.一名系统性红斑狼疮患者出现的水疱大疱性皮疹。
Ann Allergy. 1993 Mar;70(3):196-203.
8
Cutaneous lupus erythematosus: factors related to cutaneous activity and damage in a cohort of 260 patients from A Coruña, Spain.皮肤红斑狼疮：西班牙拉科鲁尼亚 260 例患者的皮肤活动和损害相关因素。
Lupus. 2020 Aug;29(9):1021-1030. doi: 10.1177/0961203320930094. Epub 2020 Jun 15.
9
Worsening skin damage in patients with cutaneous lupus erythematosus may predict development of systemic lupus erythematosus.皮肤型红斑狼疮患者皮肤损伤的恶化可能预示着系统性红斑狼疮的发生。
J Am Acad Dermatol. 2021 Feb;84(2):538-540. doi: 10.1016/j.jaad.2020.05.020. Epub 2020 May 11.
10
A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients.对皮肤型和系统性红斑狼疮患者中大疱性系统性红斑狼疮的12年回顾性研究。
Lupus. 2017 Oct;26(12):1278-1284. doi: 10.1177/0961203317699714. Epub 2017 Mar 30.
引用本文的文献
1
Topical Mupirocin Treatment Reduces Interferon and Myeloid Signatures in Cutaneous Lupus Erythematous Lesions Through Targeting of Staphylococcus Species.局部莫匹罗星治疗通过靶向葡萄球菌属减少皮肤红斑狼疮病变中的干扰素和髓系特征。
Arthritis Rheumatol. 2025 Jun;77(6):705-715. doi: 10.1002/art.43079. Epub 2025 Jan 23.
2
Assessment of cutaneous disease activity in early lupus and its correlation with quality of life: a cross-sectional study.评估早期狼疮患者的皮肤疾病活动度及其与生活质量的相关性：一项横断面研究。
Rheumatol Int. 2023 Oct;43(10):1835-1840. doi: 10.1007/s00296-023-05353-y. Epub 2023 Jun 13.
3
Molecular Characterization of Hepatitis B Virus Infection in a Patient with Cutaneous Lupus Erythematosus.一例皮肤性红斑狼疮患者乙肝病毒感染的分子特征分析
Diagnostics (Basel). 2022 Nov 19;12(11):2866. doi: 10.3390/diagnostics12112866.
4
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.德夸西替尼，一种酪氨酸激酶 2 抑制剂，在系统性红斑狼疮中的应用：一项 II 期、随机、双盲、安慰剂对照试验。
Arthritis Rheumatol. 2023 Feb;75(2):242-252. doi: 10.1002/art.42391. Epub 2022 Nov 11.
5
Diagnosis and Management of Cutaneous Manifestations of Autoimmune Connective Tissue Diseases.自身免疫性结缔组织病皮肤表现的诊断与管理
Clin Cosmet Investig Dermatol. 2022 Oct 26;15:2285-2312. doi: 10.2147/CCID.S360801. eCollection 2022.
6
Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation.非皮损性狼疮皮肤有助于髓样细胞的炎症教育，并为皮肤炎症做好准备。
Sci Transl Med. 2022 Apr 27;14(642):eabn2263. doi: 10.1126/scitranslmed.abn2263.
7
Update on Epidemiology and Clinical Assessment Tools of Cutaneous Lupus Erythematosus and Dermatomyositis.皮肤型红斑狼疮和皮肌炎的流行病学及临床评估工具的最新进展
Curr Dermatol Rep. 2013 Mar;2(1):48-57. doi: 10.1007/s13671-012-0037-3. Epub 2013 Jan 24.
8
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.注射用促肾上腺皮质激素治疗持续活动的系统性红斑狼疮：一项4期、多中心、随机、双盲、安慰剂对照试验的结果
Rheumatol Ther. 2020 Dec;7(4):893-908. doi: 10.1007/s40744-020-00236-1. Epub 2020 Sep 29.
9
Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus.评估红斑狼疮患者临床改善的稳健性测量方法。
Lupus Sci Med. 2020 Jan 27;7(1):e000364. doi: 10.1136/lupus-2019-000364. eCollection 2020.
10
Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus.评估利妥昔单抗治疗红斑狼疮皮肤病变的 B 细胞耗竭反应。
JAMA Dermatol. 2018 Dec 1;154(12):1432-1440. doi: 10.1001/jamadermatol.2018.3793.
本文引用的文献
1
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.用喹吖因和羟氯喹治疗狼疮皮肤受累。
Lupus. 2009 Jul;18(8):735-9. doi: 10.1177/0961203308101714.
2
Lupus erythematosus masquerading as erythema multiforme: does Rowell syndrome really exist?伪装成多形红斑的红斑狼疮：罗威尔综合征真的存在吗？
Dermatol Online J. 2009 Feb 15;15(2):5.
3
Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus.脉冲染料激光治疗皮肤盘状红斑狼疮的疗效和安全性。
J Am Acad Dermatol. 2009 Apr;60(4):626-32. doi: 10.1016/j.jaad.2008.11.904.
4
Clinically relevant information about cutaneous lupus erythematosus.关于皮肤红斑狼疮的临床相关信息。
Arch Dermatol. 2009 Mar;145(3):316-9. doi: 10.1001/archdermatol.2008.582.
5
Lenalidomide for the treatment of resistant discoid lupus erythematosus.来那度胺治疗难治性盘状红斑狼疮。
Arch Dermatol. 2009 Mar;145(3):303-6. doi: 10.1001/archdermatol.2009.30.
6
Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.肿胀性红斑狼疮：36例患者对抗疟治疗的反应，重点关注吸烟情况
Arch Dermatol. 2009 Mar;145(3):244-8. doi: 10.1001/archdermatol.2008.592.
7
The 100th anniversary of lupus erythematosus tumidus.肿胀性红斑狼疮100周年。
Autoimmun Rev. 2009 May;8(6):441-8. doi: 10.1016/j.autrev.2008.12.010. Epub 2009 Jan 20.
8
Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation.药物性亚急性皮肤型红斑狼疮：一项以患者为导向、从床边到实验室的转化性临床研究范例。
Arch Dermatol Res. 2009 Jan;301(1):65-70. doi: 10.1007/s00403-008-0890-x. Epub 2008 Sep 17.
9
Drug-induced lupus erythematosus.药物性红斑狼疮
Arch Dermatol Res. 2009 Jan;301(1):99-105. doi: 10.1007/s00403-008-0895-5. Epub 2008 Sep 17.
10
Lupus erythematosus panniculitis.红斑狼疮性脂膜炎。
Dermatol Clin. 2008 Oct;26(4):453-63, vi. doi: 10.1016/j.det.2008.06.002.
Zotero 插件